US · Financial Services

Rapid Therapeutic Science Lab inc (RTSL)

Shell Companies

Rapid Therapeutic Science Lab inc (RTSL) is listed on US in the Financial Services sector. Industry: Shell Companies. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for RTSL

P/E ratio

18.00

Rapid Therapeutic Science Lab inc (RTSL) — FAQ

What is RTSL's P/E ratio?

The price-to-earnings (P/E) ratio for Rapid Therapeutic Science Lab inc (RTSL) is 18.00 (data as of 2026-05-23).

Does Rapid Therapeutic Science Lab inc pay a dividend?

Dividend yield is not available in the current snapshot for Rapid Therapeutic Science Lab inc (RTSL). Check the MyAverix Finance app for the latest dividend data.

What sector is Rapid Therapeutic Science Lab inc in?

Rapid Therapeutic Science Lab inc (RTSL) is classified in the Financial Services sector (Shell Companies industry).

What exchange is RTSL listed on?

RTSL is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Financial Services companies

Administradora Americana de Inversiones S.A. (AAISA) Aflac Incorporated (A1FL34) Agricultural Bank Of China (1288) AIA Group Ltd (1299) American International Group, Inc. (AIGB34) Ameriprise Financial Inc. (A1MP34) Arthur J. Gallagher & Co. (A1JG34) Banco Santander S.A. (BSD2)